Evidence map›Paper›PMID 33489093›Full record

ReviewClinical liver disease2020

Alcohol-Associated Liver Disease: East Versus West.

Phunchai Charatcharoenwitthaya, Suthat Liangpunsakul, Teerha Piratvisuth

Abstract readReview
In one paragraph

Review in Clinical liver disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Alcohol-associated liver disease.The Journal of clinical investigation · 2024
    Review
  5. Article
  6. Metabolic Phenotypes: Drivers of Health Outcomes in Fatty Liver Diseases.Journal of clinical and translational hepatology · 2023
    Article
  7. Article
  8. Global epidemiology of cirrhosis - aetiology, trends and predictions.Nature reviews. Gastroenterology & hepatology · 2023
    Review
  9. Review
  10. Article
  11. Emerging Biomarkers in Alcohol-associated Hepatitis.Journal of clinical and experimental hepatology
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Phunchai CharatcharoenwitthayaDivision of Gastroenterology Department of Medicine Faculty of Medicine Siriraj Hospital Mahidol University Bangkok Thailand.
Suthat LiangpunsakulDivision of Gastroenterology and Hepatology Department of Medicine Indiana University School of Medicine Indianapolis IN.
Teerha PiratvisuthDivision of Gastroenterology and Hepatology Department of Medicine Faculty of Medicine Prince of Songkla University Songkhla Thailand.

Funding

Novel biomarkers as a clinical tool for excessive alcohol use screeningR01AA025208 · NIAAA · INDIANA UNIVERSITY INDIANAPOLIS · PI LIANGPUNSAKUL, SUTHAT, TU, WANZHU · 2016 to 2020
$1.7M
Sestrin3 in the pathogenesis of alcoholic and non-alcoholic fatty liver diseaseR01DK107682 · NIDDK · INDIANA UNIVERSITY INDIANAPOLIS · PI DONG, X. CHARLIE, LIANGPUNSAKUL, SUTHAT · 2016 to 2019
$1.4M
Immunological Profiles and prognostic outcomes in patients with alcoholic hepatitisU01AA026917 · NIAAA · INDIANA UNIVERSITY INDIANAPOLIS · PI LIANGPUNSAKUL, SUTHAT · 2018 to 2022
$1.2M
Novel animal models to study miRNA-mediated alcoholic liver diseaseUH2AA026903 · NIAAA · INDIANA UNIVERSITY INDIANAPOLIS · PI LIANGPUNSAKUL, SUTHAT · 2018 to 2019
$447k
CSRD VA I01 CX000361NIAAA NIH HHS R01 AA025208NIAAA NIH HHS U01 AA026917NIAAA NIH HHS UH2 AA026903NIDDK NIH HHS R01 DK107682
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID33489093
PMCPMC7805304

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.